首页> 外文期刊>Key Engineering Materials >Antibiotic-containing polylactide-co-glycolide and porous β-tricalcium phosphate composite for treating osteomyelitis
【24h】

Antibiotic-containing polylactide-co-glycolide and porous β-tricalcium phosphate composite for treating osteomyelitis

机译:含抗生素的聚丙交酯-乙交酯和多孔β-磷酸三钙复合材料治疗骨髓炎

获取原文
获取原文并翻译 | 示例
           

摘要

A composite of co-polymer of lactic and glycolic acids (PLGA) loaded with gatifloxacine (GFLX), an antibiotics, and a β-tricalcium phosphate (βTCP) porous ceramic body was prepared by a solvent-free process in which no toxic solvent was used. The GFLX-loaded PLGA released GFLX for 8 weeks in Hanks' balanced solution. The inhibitory zone diameter (26.25 ± 0.95 mm) for GFLX-containing PLGA disk against S. milleri was significantly larger than 18 mm, and comparable to that (24.88 ± 1.6 mm) for the KB paper disk containing 5 fig of GFLX/disk. This means that the GFLX-containing PLGA has the clinical efficacy. The molten PLGA containing GFLX was successfully loaded in the pores and on the surface of the porous PTCP ceramic at 120℃ at a reduced pressure of 0.02 MPa. The composite of GFLX-loaded porous PTCP ceramic would be promising for treating osteomyelitis.
机译:乳酸和乙醇酸共聚物(PLGA)负载加替沙星(GFLX),抗生素和β-磷酸三钙(βTCP)多孔陶瓷体的复合材料是通过无溶剂工艺制备的,其中没有有毒溶剂用过的。装有GFLX的PLGA在汉克斯的平衡解决方案中发布了8周的GFLX。含GFLX的PLGA圆盘对粟米链霉菌的抑制区直径(26.25±0.95 mm)显着大于18 mm,与包含5个无花果的GFLX /圆盘的KB纸盘的抑制区直径(24.88±1.6 mm)相当。这意味着含GFLX的PLGA具有临床功效。将含有GFLX的PLGA熔融液在0.02 MPa的减压下成功地在120℃的孔隙和多孔PTCP陶瓷的表面加载。载有GFLX的多孔PTCP陶瓷的复合材料有望用于治疗骨髓炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号